KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Common Equity (2016 - 2026)

Gilead Sciences filings provide 17 years of Common Equity readings, the most recent being $22.7 billion for Q4 2025.

  • On a quarterly basis, Common Equity rose 17.45% to $22.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $22.7 billion, a 17.45% increase, with the full-year FY2025 number at $22.7 billion, up 17.45% from a year prior.
  • Common Equity hit $22.7 billion in Q4 2025 for Gilead Sciences, up from $21.5 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $22.7 billion in Q4 2023 to a low of $17.5 billion in Q1 2024.
  • Median Common Equity over the past 5 years was $20.6 billion (2022), compared with a mean of $20.3 billion.
  • Biggest five-year swings in Common Equity: rose 22.9% in 2021 and later decreased 17.32% in 2024.
  • Gilead Sciences' Common Equity stood at $21.1 billion in 2021, then increased by 0.69% to $21.2 billion in 2022, then grew by 7.26% to $22.7 billion in 2023, then dropped by 15.03% to $19.3 billion in 2024, then increased by 17.45% to $22.7 billion in 2025.
  • The last three reported values for Common Equity were $22.7 billion (Q4 2025), $21.5 billion (Q3 2025), and $19.6 billion (Q2 2025) per Business Quant data.